In Reply to Sari et al.

Aksnessæther, Bjørg Y; Myklebust, Tor Åge; Solberg, Arne; Klepp, Olbjørn H; Skovlund, Eva; Hoff, Solveig Roth; Fosså, Sophie D; Widmark, Anders; Lund, Jo-Åsmund

In Reply to Sari et al.

Aksnessæther, Bjørg Y; Myklebust, Tor Åge; Solberg, Arne; Klepp, Olbjørn H; Skovlund, Eva; Hoff, Solveig Roth; Fosså, Sophie D; Widmark, Anders; Lund, Jo-Åsmund.

Affiliation

Aksnessæther BY; Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Myklebust TÅ; Department of Research and Innovation, Møre and Romsdal Hospital Trust, Norway; Department of Registration, Cancer Registry of Norway, Oslo, Norway.
Solberg A; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway; Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Klepp OH; Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway.
Skovlund E; Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
Hoff SR; Department of Radiology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Ålesund, Norway; Department of Circulation and Medical Imaging, Faculty of Medicine and Health Sciences, NTNU, Trondheim, Norway.
Fosså SD; Department of Oncology, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Widmark A; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.
Lund JÅ; Department of Oncology, Ålesund Hospital, Møre and Romsdal Hospital Trust, Norway; Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.

Int J Radiat Oncol Biol Phys ; 107(2): 388-389, 2020 06 01.

Article de En | MEDLINE | ID: mdl-32112877

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de la prostate / Seconde tumeur primitive Type d'étude: Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Humans / Male Langue: En Journal: Int J Radiat Oncol Biol Phys Année: 2020 Type de document: Article Pays d'affiliation: Norvège

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google